Sign in
4

Changes in Ownership

ImmunityBio, Inc. Filed Acc 0001647994-26-000004

Director sold 175,000 shares at an average $10.19 ($1,783,602)

  • Director gave up 6,026 shares (to pay taxes)
  • Director acquired 15,243 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Simon Barry J. · Director

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2026-02-20 Sale : show line 1 in the form 10b5-1 −10,000 $9.25 $92,500 3,081,604 D
2026-02-22 Exercise or conversion : show line 2 in the form 10b5-1 +15,243 3,096,847 D
2026-02-22 Shares withheld for taxes : show line 3 in the form 10b5-1 −6,026 $8.70 $52,426 3,090,821 D
2026-02-23 Sale : show line 4 in the form 10b5-1 −165,000 $10.25 $1,691,102 2,925,821 D
Open-market sales · 175,000 sh · avg $10.19 · $1,783,602

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-02-22 Exercise or conversion : show line 5 in the form 10b5-1 Restricted Stock Units −15,243 15,245 D
Loading xslF345X05/wk-form4_1771981423.xml…